APACC 2021


Welcome Message 

Dear colleagues,

It is our pleasure to announce that the Asia-Pacific AIDS & Co-Infections Conference (APACC) 2021 will be held virtually in June 2021. The exact dates will be announced soon.

Over the years, enormous progress has been made in the fight against HIV and co-infections with HIV. Both academia and industry have contributed greatly to equipping the medical community with the best medications and expertise possible to optimally treat their HIV and co-infected patients. However, international platforms for scientific interchange are not always accessible to medical professionals worldwide due to budget and travel restrictions. Also, most major conferences do not usually address local and regional issues. In particular, the Asian medical community in this field of research currently has very few platforms that serve the needs of HIV healthcare professionals in this region.

APACC provides a much-needed scientific platform that focuses on the developments, issues, and needs in the Asia Pacific region. Researchers have the opportunity to present and discuss the latest developments and are offered opportunities for interaction, networking, and building collaborations. Top experts integrate science and clinical practice through state-of-the-art lectures, clinical case discussions, round table discussions, and debates in order to reach consensus on best practices and inform how treatment guidelines are implemented.

We look forward to meeting you on virtual APACC 2021!

Chairs 2021

Unique Features

  • A program with a special focus on the needs in Asia and the Pacific
  • A true scientific platform for regional clinicians and clinical researchers to present their data
  • Insights into important clinical developments and updates on ongoing and new trials
  • Capacity building workshops and career development sessions for young professionals
  • A great opportunity to network with your colleagues throughout Asia

Who Should Attend?

  • Medical professionals involved in the daily care of individuals infected with HIV and HIV-HCV, HIV-HBV, HIV-TB, and other HIV co-infections
  • Clinical, translational, and basic researchers
  • Clinicians, physicians, general practitioners, and nurses
  • Residents, post-graduates, and PhD students
  • Government agency personnel, NGO representatives, and  health authority personnel
  • Industry representatives
  • Social workers, advocates, and community workers
  • Other healthcare professionals involved in treating HIV and co-infected patients

Meeting Objectives

This meeting aims to:

  • Promote dissemination and successful translation of new knowledge regarding HIV and co-infections while facilitating a neutral environment
  • Foster new and lasting cross-disciplinary partnerships and collaborations between researchers in HIV, hepatitis, tuberculosis, policymakers, and NGOs, among others, in order to improve  knowledge sharing, with the end goal of improving healthspan within the rapidly growing HIV/AIDS population
  • Attract, showcase, and maintain new, early career, and underrepresented investigators to this multidisciplinary area of research and to translate novel findings into clinical practice

Learning Objectives

After participating in this activity, the participants will be able:

  • Describe the major achievements and challenges in antiviral therapy for HIV and/or hepatitis-positive patients in the Asia Pacific region 
  • Identify improved treatment options for their patients
  • Initiate (research) collaborations to further improve the level of knowledge on clinical management in the Asia Pacific region
  • Use gained knowledge to make/advocate for appropriate adjustments to policies in public, institutional, and private settings